Webinar
Read more about the webinar - Development of CRISPR/Cas9-based Therapies against Alzheimer's Disease
Researchers have successfully used CRISPR-Cas9 to selectively disrupt a mutant PSEN1 allele that causes familial Alzheimer’s disease. In this...